Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,792	1,960	1,829	1,318	1,260	985
Market Cap Growth	-1.33%	7.12%	38.81%	4.57%	27.92%	-14.60%
Enterprise Value	2,343	2,445	2,240	1,629	1,521	1,202
Last Close Price	746.60	815.42	760.13	546.57	521.71	407.85
PE Ratio	371.72	369.08	188.91	144.98	156.37	-
PS Ratio	9.24	8.50	8.34	6.65	6.96	9.95
PB Ratio	53.44	60.61	62.17	56.46	23.92	21.97
P/TBV Ratio	53.44	60.61	62.17	56.46	23.92	21.97
P/OCF Ratio	120.30	90.16	-	-	-	-
EV/Sales Ratio	12.08	10.61	10.22	8.22	8.40	12.14
EV/EBITDA Ratio	-	196.29	122.73	80.79	77.41	-
EV/EBIT Ratio	-	330.94	180.50	123.64	102.35	-
EV/FCF Ratio	-263.26	-	-	-	-	-
Debt / Equity Ratio	20.36	19.76	0.03	16.82	6.55	5.35
Debt / EBITDA Ratio	94.47	49.53	0.05	18.95	16.49	-
Net Debt / Equity Ratio	16.44	15.66	-1.08	15.59	6.22	5.01
Net Debt / EBITDA Ratio	-	40.65	-1.75	18.05	16.70	-134.45
Net Debt / FCF Ratio	-61.94	-245.76	0.47	-10.30	-4.39	-41.23
Asset Turnover	0.28	0.35	0.40	0.39	0.39	0.23
Inventory Turnover	0.45	0.55	0.49	0.49	0.54	0.40
Quick Ratio	0.47	0.47	0.38	0.34	0.29	0.29
Current Ratio	0.84	0.83	0.91	0.88	0.92	0.87
Return on Equity (ROE)	14.91%	17.19%	36.70%	23.91%	16.53%	-25.34%
Return on Assets (ROA)	0.62%	0.70%	1.41%	1.62%	2.01%	-1.07%
Return on Invested Capital (ROIC)	0.87%	2.00%	5.28%	2.92%	3.60%	-2.68%
Return on Capital Employed (ROCE)	18.20%	20.30%	36.30%	44.70%	24.80%	-13.70%
Earnings Yield	0.27%	0.27%	0.53%	0.69%	0.64%	-1.32%
FCF Yield	-0.50%	-0.10%	-3.72%	-2.68%	-5.93%	-0.55%
Dividend Yield	0.13%	0.12%	0.13%	0.27%	0.19%	-
Payout Ratio	49.77%	44.23%	34.91%	11.00%	18.61%	-
Total Shareholder Return	0.13%	0.12%	0.13%	0.27%	0.19%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.